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1. Introduction
In addition to original articles, the Journal of Oral Biosciences also
published review articles by prize winners of the “Lion Dental
Research Award” and the “Rising Members Award,” presented by
the Japanese Association for Oral Biology. The Journal also publishes
review articles featuring recent information presented in symposia
held during the annual meeting of the Association. In 2013, we
published special issues featuring the following reviews: “Considerable
aspects in dental stem cells,” “Challenge for new horizon of bone
research,” “Dynamism of the extracellular environment in tooth
morphogenesis,” “Pursuing a progress in taste research based on its
history and heritage—generation and transmission of taste informa-
tion,” “Frontier in research on salivary gland morphogenesis—mole-
cular and cellular mechanisms of organogenesis,” “Exploring the
phylogenic evolution of vertebrate hard tissues from teeth and scales,”
“Application of adipose-derived mesenchymal stem cells for regen-
erative medicine,” “Oral microbiome and bioﬁlm research: new
concepts and new approaches,” “A new concept of bioﬁlm-mediated
oral diseases—symbiosis and dysbiosis—,” “Mouse genetics approaches
decipher molecular mechanisms of craniofacial development,” and
“Cutting edge and perspective of iPS cells research in dental medicine”.
These reviews in the Journal of Oral Biosciences have inspired the
readers of the Journal to broaden their knowledge regarding the
various aspects of oral biosciences. This editorial review introduces
these exciting studies in the following pages.
2. “Considerable aspects in dental stem cells”
Tooth development is regulated by epithelial–mesenchymal inter-
actions. This epithelial-mesenchymal crosstalk is mediated by a
relatively small number of signaling pathways, including the WNT,
ﬁbroblast growth factor (FGF), transforming growth factor-β (TGF-β),
hedgehog (HH), and tumor necrosis factor (TNF) families and their
downstream transcription factors, which are used reiteratively during
development [1]. In his review article, Yamashiro focused on the
functions of Runx/Cbfb genes in the maintenance of the epithelial
stem cell compartment and their subsequent continuous differentia-
tion in rodent incisors [2]. Rodent incisors constitute a unique
experimental model for examining the mechanisms of stem cell
maintenance because they grow continuously throughout the lifetime
of the animal and their regenerative capacity implies the presence of
stem cell pools [3,4]. The three mammalian Runx genes encode the
transcription factors that share a conserved region of 128 amino acids
termed the Runt domain [5]. Runx genes encode the α subunits of the
Runt domain transcription factors, RUNX1 (AML1/CBFA2/PEBP2AB),
RUNX2 (AML3/CBFA1/PEBP2AA), and RUNX3 (AML2/CBFA3/
PEBP2AC), and they combine with the β subunit, CBF-β, to form
heterodimeric transcription factors, which play important roles in
both normal developmental processes and carcinogenesis [6]. All
three Runx genes are expressed in the dental epithelium and/or
mesenchyme during tooth development and display distinct spatio-
temporal patterns [7]. Mice deﬁcient in epithelial Cbfb (K14-Cre;
Cbfbﬂ/ﬂ mice) fail to produce a fully developed cervical loop in their
incisors, which results in short incisors. Cbfbmutants also lack enamel
formation and display downregulated Shh mRNA expression in cells
that differentiate into ameloblasts. Fgf9 deﬁciency results in a
proximal shift of the Shh-expressing cell population, and ectopic
FGF-9 proteins suppress Shh mRNA expression. Runx genes are
involved in the continuous elongation of incisors by sustaining the
expression of Fgf9 and Shh, whose complementary functions allow
the retention of an Fgf9-expressing transit-amplifying domain and an
Shh-expressing differentiation domain [8].
3. “Challenge for new horizon of bone research”
Patients with advanced atherosclerosis, especially those suffering
from chronic renal failure and diabetes mellitus, often exhibit
vascular calciﬁcation that results in reduced elasticity of the arteries
[9–11]. The importance of medial calciﬁcation has been described;
however the molecular and cellular mechanisms involved have not
yet been fully deﬁned [12]. Amizuka and colleagues explained their
understanding of the vascular medical calciﬁcation process in klotho-
deﬁcient (kl/kl) mice on the basis of their histological examinations of
the aorta in their review article [13]. Unlike normal vascular smooth
muscle cells (VSMCs), tunica media cells of kl/kl mice developed
cisterns of rough endoplasmic reticulum and Golgi apparatus; they
resembled matrix-synthesizing cells rather than authentic VSMCs.
Additionally, many matrix vesicle-like structures and calcifying
nodules were observed in the vicinity of these VSMC-like cells in
kl/kl tunica media. In conclusion, developed vascular medical calci-
ﬁcation in kl/kl mice seems to be caused by hyperphosphatemia
rather than the absence of aging suppression. The ﬁndings suggest
two possible pathways of vascular calciﬁcation: one involves matrix
vesicle-like structures that could include mineral crystals, and
the other involves the deposition of calcium phosphates within the
amorphous materials. The former pathway indicates the possibility of
VSMC transdifferentiation into the osteoblastic lineage. However,
further studies are needed to elucidate the biological characteristics
of the matrix vesicle-like structures and the mechanism of VSMC
differentiation into the osteoblastic phenotype.
Tetracyclines are widely used to treat infectious diseases [14].
Since minocycline and doxycycline have been shown to prevent
bone loss [15–18], tetracyclines are now proposed to be
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therapeutic agents for diseases with bone loss, such as malignancy,
arthritis, and periodontitis [15,19,20]. Although tetracyclines have
been shown to inhibit bone resorption, the mechanisms of their
inhibitory action remain largely unknown [21–24]. Udagawa and
colleagues introduced the effects of doxycycline and minocycline
on the formation of osteoclasts in vitro and in vivo in their review
article [25]. Doxycycline and minocycline inhibited RANKL-
induced osteoclastogenesis. In the presence of RANKL, tetracy-
clines convert the differentiation pathway, which results in
dendritic cell (DC)-like cells rather than osteoclasts, both in vitro
and in vivo [26]. The RANKL–RANK system was ﬁrst considered as
a cytokine-receptor interaction that regulates DC function [27–29]
and was subsequently found to be involved in osteoclastogenesis.
The RANKL–RANK interaction is involved in minocycline induced
DC-like cell differentiation. Udagawa and colleagues also sug-
gested that minocycline induces DC-like cell differentiation at
sites of RANKL expression. In addition, minocycline has been
shown to suppress inﬂammation [30–33]. The development of a
drug delivery system for minocycline will make it possible for
minocycline to be used to suppress bone loss induced by local
inﬂammation, including that observed in rheumatoid arthritis and
periodontitis [25].
Vibrational spectroscopic techniques, including infrared (IR)
and Raman spectroscopy, are powerful tools for characterizing the
chemical compositions of materials because they can provide both
qualitative and quantitative information on molecular structure.
Boskey and collaborators focused on collagen cross-links in bone
and characterized the nonreducible:reducible collagen cross-link
ratio in the diseased bone matrix using Fourier transform infrared
(FTIR) microspectroscopy and FTIR imaging [34], while Morris
and colleagues characterized microcracks in bone mineral using a
newly developed Raman system [35]. However, further detailed
studies on the various bones are required to better understand
bone quality. Kimura-Suda and colleagues described recent
advances in the analysis of bone metabolism by using isotope
microscopy, FTIR imaging, and micro-Raman spectroscopy [36,37].
Isotope microscopy, FTIR imaging, and micro-Raman spectroscopy
are nondestructive tools used to characterize bone quality and do
not require the use of stains. Such nondestructive analyses are
suitable for evaluating heterogeneous tissues and provide infor-
mation about the distribution of molecules. Comprehensive ana-
lysis using isotope microscopy, FTIR imaging, and micro-Raman
spectroscopy may provide more information on bone quality
compared with using a single technique. Thus, it is important to
standardize sample preparation and measurement techniques.
4. “Dynamism of the extracellular environment
in tooth morphogenesis”
Perlecan, a basement membrane-type heparan sulfate proteo-
glycan, is a macromolecule originally identiﬁed in the basement
membrane [38]. Although it exists predominantly in the basement
membrane and extracellular matrix (ECM) [39–41], perlecan has
been recently found to accumulate within epithelial tissues in
pathophysiological conditions [42–44]; the in situ intra-epithelial
deposition of perlecan is substantial in tumor cell nests of amelo-
blastomas [42] and in oral squamous cell carcinomas [43], and
perlecan-deﬁcient keratinocytes form a strikingly thin and poorly
organized epidermis and fail to complete their stratiﬁcation
program [44]. Thus, perlecan regulates the survival, growth, and
differentiation of epithelial cells interacting with perlecan-binding
soluble factors within epithelial tissue. Ida-Yonemochi focused on
perlecan as a major constituent of the intra-epithelial stroma of
the enamel organ in her review article [45]. Their recent study
demonstrated that perlecan accumulates in the stellate reticulum
of the enamel organ of murine molar tooth germs in a stage-
speciﬁc manner [46]. To understand the function of perlecan in the
enamel organ, they generated transgenic (Tg) mice that over-
expressed perlecan in epithelial cells by using the keratin 5 pro-
moter [47]. Perlecan Tg molars had dull-ended crowns and
outward-curved tooth roots, and their enamel was poorly crystal-
lized. The constant overexpression of perlecan and the accompa-
nying disorganized distribution of perlecan-related molecules in
the enamel organ resulted in irregular tooth morphology. These
results indicated that the timing of intra-epithelial perlecan
expression appears to be precisely controlled during enamel organ
development.
Bone is formed by two different processes: endochondral
ossiﬁcation and intramembranous ossiﬁcation [48]. Endochondral
ossiﬁcation contributes to the formation of most bones in
the body, and its process involves a series of events including
mesenchymal condensation, formation of cartilage, apoptosis of
mature hypertrophic chondrocytes, removal of mineralized carti-
lage with vascularization, and trabecular bone formation. In
contrast, the process of intramembranous ossiﬁcation involves
bone formation by osteoblasts in the absence of a cartilaginous
scaffold. Gap junctions play a critical role in the differentiation of
chondrocytes and osteoblasts. Chondrocytes express connexin (Cx)
43 and pannexin (Panx) 3 [49,50], and osteoblasts express Cx43,
Cx45, Cx46, and Panx3 [48,49]. Iwamoto and colleagues reviewed
the recent ﬁndings on gap junction proteins in cartilage and bone
development [51]. Since the discovery of the two gap junction
protein families, Cx and Panx, studies have shown that most cell
types express more than one Cx or Panx and that these proteins
have unique and important functions in differentiation and dis-
eases via cell–cell or cell–matrix communication and cell signal-
ing. Panx3 is induced during chondrogenesis and osteogenesis.
Panx3 antagonizes PTH-mediated chondrocyte proliferation
through a hemichannel and promotes differentiation. Additionally,
Panx3 promotes osteoblast differentiation through a hemichannel,
an endoplasmic reticulum Ca2þ channel, and a gap junction.
Panx3 acts as a novel regulator involved in the process of switch-
ing from cell proliferation to differentiation. Further in vivo ana-
lysis of Panx3 will help to elucidate the mechanisms of cartilage
and bone development and diseases.
5. “Pursuing a progress in taste research based on
its history and heritage-generation and transmission
of taste information”
The taste system is critical for evaluating food sources and is
responsible for detecting various compounds in food that signal
the availability of caloric energy, as well as those that indicate the
presence of toxins. By detecting such compounds, the gustatory
system triggers innate behaviors based on the acceptance or
rejection of potential food items [52]. Mammals can detect and
discriminate between sweet, bitter, sour, salty, and umami stimuli
[53]. Bitter is the primary taste modality that elicits aversive
responses, whereas humans are attracted by sweet tastants. Since
the sense of taste evokes stimulus-speciﬁc behavioral and emo-
tional responses, the gustatory system provides a simple model to
investigate general neuronal mechanisms underlying cognition,
behavioral and emotional responses, and learning. Sugita and
colleagues discussed recent characterizations of the molecular,
cellular, and systems-level mechanisms involved in the detection
and perception of sweet and bitter taste [54,55]. In addition, taste
sensory coding, palatability coding, and the taste-guided mechan-
isms for feeding were considered. There is a distinct beauty in the
functional architecture of the gustatory relays and cortex in
the brain that mediate the processing of sweet and bitter taste
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information. However, the exact mechanisms through which
sweet and bitter taste information evokes contrastive emotional
and behavioral responses remain elusive. Each of the gustatory
nuclei in the brain appears to contain a heterogeneous population
of neurons that expresses a variety of neuropeptides and neuro-
transmitter/neuromodulator-synthesizing enzymes. An approach
to selectively manipulate the activities of cognate populations
among taste-relaying neurons with different neurotransmitters
and distinct projection sites may help to deﬁne the functional
diversity and evoked responses of taste-responsive neurons.
6. “Frontier in research on salivary gland
morphogenesis—molecular and cellular mechanisms
of organogenesis”
Branching morphogenesis is an important process in the
development of numerous organs, including lungs, kidneys, mam-
mary glands, and salivary glands [56]. During branching, a cleft
forms and extends deeper into the local epithelium. The factors
required for local extension of the cleft, including several growth
factors, have been previously identiﬁed [57–60]. However, the
molecular mechanisms underlying cleft formation are not known.
Sakai and Onodera determined that the ﬁbronectin-induced gene
BTB (POZ) domain containing 7 (Btbd7)/Cleftin plays an important
role in this process and analyzed how this gene regulates cleft
formation [61]. Sakai and colleagues observed that Btbd7/Cleftin
induces branching morphogenesis; Btbd7/Cleftin is activated by
the ECM, and it can then locally regulate E-cadherin and Snail2
(Slug) expression to form the cleft. Btbd7/Cleftin is essential for
formation of the embryonic salivary glands and lungs because
it regulates both branching morphogenesis and epithelial tissue
remodeling [62]. They previously presented a putative model
mechanism for cleft formation. In this model, deposition of the
ECM in the cell gap decreases epithelial cell–cell adhesion.
Fibronectin, an ECM protein, is essential for cleft formation, and
its localization around the cleft reduces the local levels of
E-cadherin, which is important for cell–cell adhesion [63]. Knock-
down of Btbd7/Cleftin expression conﬁrmed that the loss of cell–
cell adhesion observed following addition of ﬁbronectin was
caused by Btbd7/Cleftin expression [64]. These results provide a
preliminary outline of the molecular mechanisms involved in
Btbd7/Cleftin-induced cleft formation. Fibronectin, Btbd7/Cleftin,
and Snail2 accumulate locally at the cleft and regulate cell
adhesion around the cleft. Btbd7/Cleftin subsequently reduces
E-cadherin levels, which leads to disruption of the cell arrange-
ment and reduction in cell-cell adhesion. Because these processes
occur at the bottom of the cleft, the gap between the epithelial
cells increases, and a cleft forms. This process is an important
molecular mechanism in cleft formation, which leads to branching
morphogenesis of epithelial cells [61].
7. “Exploring the phylogenic evolution of vertebrate hard
tissues from teeth and scales”
Regarding the origin of teeth, the mouth cavity is thought to be
formed by the invagination of external body skin (stomodeum)
and that dentition arose from the skin denticles (scales). Dentition
and skin denticles (scales) are homologous structures that origi-
nate from the ectoderm [65] (“outside-in” theory [66]). A homolog
with teeth, present in the pharyngeal region, has been reported in
Paleozoic jawless ﬁsh, which suggests that teeth developed within
the pharynx, independent of both the skin denticles and the
appearance of jaws [67,68]. Although problems concerning the
origin of teeth are still controversial, our understanding of their
developmental aspects has progressed in recent years [69,70].
Comparative analysis of dentition teeth and scales in ﬁsh has
contributed to revelations on the origin and early evolution of
teeth. Investigating the morphological and histochemical features
of these organs during their developmental process in extant bony
ﬁsh may provide important information. Although there have
been a number of reports on the morphological aspects (tissue
and cells) of teeth and scales, the features of organic matrices,
especially matrix proteins, and the inorganic phase (crystals) are
still unclear. In their review article, Sasagawa and colleagues
discussed enamel, enameloid, and the ganoine layer, i.e., the
outer layer of ganoid scales, in Polypterus and Lepisosteus, which
belong to the extant basal group of actinopterygian ﬁsh [71].
Enameloid is a well-mineralized tissue that is formed by both
odontoblasts and dental epithelial cells and is found within the
outermost layer of dentin [72–74]. The inner dental epithelial
cells surrounding the enameloid maintain the ability to produce
amelogenin-like proteins, although this may be a rudimentary
function. The collar enamel of Polypterus and Lepisosteus exhibits
marked immunoreactivity to anti-mammalian amelogenin anti-
bodies, suggesting that it accommodates amelogenin-like pro-
teins. It is likely that the collar enamel in basic actinopterygians
corresponds to the enamel in sarcopterygians and amphibians.
Recent ﬁne structural and developmental studies have shown
that the ganoine of ganoid scales in Polypterus and Lepisosteus is
an enamel-like tissue. Positive immunoreactivity to anti-
mammalian amelogenin antibodies by preganoine from both
Polypteridae and Lepisosteidae supports that ganoine is a homolog
of tooth enamel [75,76].
Enamel is commonly found in sarcopterygians (tetrapods,
lungﬁsh, and coelacanth), but it is not common in other verte-
brates. In cartilaginous ﬁsh and most actinopterygians (ray-ﬁnned
ﬁsh), the tooth surface is covered with enameloid instead of
enamel [77]. Unlike enamel, the matrix of enameloid contains
collagen and is secreted mainly by odontoblasts in cartilaginous
ﬁsh and by both odontoblasts and inner dental epithelial cells in
ray-ﬁnned ﬁsh [78–81]. Nevertheless, enameloid grows into a
hypermineralized tissue through maturation processes, similar to
enamel. Interestingly, the odontogenic ameloblast-associated pro-
tein (ODAM, previously called APin) gene is expressed during the
maturation stage of enamel in mammals and of enameloid in
zebraﬁsh [81,82]. These ﬁndings suggest that ODAM is a major
player in hypermineralization [83]. In contrast, amelotin (AMTN) is
expressed in maturation-stage ameloblasts, but not in odonto-
blasts, dental pulp cells, or alveolar osteoblasts [84]. In separate
studies, AMTN was shown to be expressed in enamel during the
maturation stage of amelogenesis [85,86]. Furthermore, Kawasaki
and colleagues reported AMTN as an uncharacterized, calcium-
binding phosphoprotein (SCPP) gene [83,87,88], showing a close
afﬁnity to the ameloblastin (AMBN) gene and the enamelin (ENAM)
gene [89]. They focused on the roles of these genes in the
maturation of enamel and/or enameloid. In postsecretory stages
of amelogenesis, a basal lamina (BL) separates the apical surface of
ameloblasts and the hypermineralizing enamel surface. This BL is
highly specialized in composition; it is largely or completely
devoid of type-IV collagen, but contains both ODAM and AMTN
in mammals. Although the functions of these proteins are not well
understood, recent studies have suggested that these proteins
mediate the attachment of the BL to the enamel surface and/or
promote the formation of the compact prismless enamel surface.
Furthermore, the ﬁndings of this study suggest that these proteins
generate and maintain the interface between unmineralized and
hypermineralizing domains. This interface appears to facilitate
efﬁcient transfer of degraded enamel matrix proteins and calcium
phosphate between these two domains, an essential process for
hypermineralization [90].
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Sulfated glycoconjugates (S-GCs) are essential components of
dentinogenesis and osteogenesis [91–97] and are involved in the
regulation of the mineralization process. Dentine is an essential
tissue of teeth and is considered to have ﬁrst appeared phylogen-
etically as a protective cover of skin in the exoskeleton of ancestral
jawless vertebrates [98]. Bone also appears to be phylogenetically
associated with the exoskeletal dermal armor; however, it is
unclear which arose ﬁrst. The scales of Polypterus senegalus, which
are homologous to teeth and phylogenetically derived from
ancestral dermal skeleton, comprise true enamel, dentine, and bone.
As part of the phylogenic evolutional studies on mesenchyme-
derived hard tissues, Kogaya and colleagues investigated the ultra-
structural distribution patterns and histochemical properties of
S-GCs in the dentine and bone of scales [99]. S-GCs were observed
in unmineralized predentine, osteoid mineralized dentine, and
osteocyte pericellular matrix, but not in mineralized bone and
isopedine. Moreover, most S-GCs in the dentine and osteoid are
susceptible to testicular hyaluronidase, indicating that they are
chondroitin sulfates. In conclusion, there are distinct differences in
the distribution patterns of S-GCs between the dentine and bone of
the scales of P. senegalus. Chondroitin sulfates in the dentine are
retained even after dentine mineralization. In contrast, S-GCs in the
bone are mostly degraded during or prior to mineralization. There-
fore, the process through which the tissues are mineralized without
removal of S-GCs represents a more primitive mechanism of
mineralization.
8. “Application of adipose-derived mesenchymal stem cells for
regenerative medicine”
The focus of tissue engineering in dentistry is the regeneration
of missing oral tissues. In particular, the restoration or regenera-
tion of periodontal tissues and bone is a major concern to clinical
dentists. Mesenchymal stem cells (MSCs) have great potential for
use in tissue repair and regeneration. Researchers have recently
reported that bone marrow (BM)-derived MSCs promote period-
ontal tissue regeneration and bone tissue engineering [100,101],
although the mechanisms regulating these processes have not
been elucidated [102,103]. The search for more readily accessible
sources of pluripotent cells has led to the investigation of other
tissues, including mobilized peripheral blood [104], umbilical cord
blood [105], and adipose tissue [106,107]. Adipose tissue is a
ubiquitously available source of stem cells, and the cells obtained
from this tissue have several advantages compared to cells from
other sources. Tobita discussed the fundamentals of periodontal
tissue regeneration and bone tissue engineering; the current state
of research in this ﬁeld is highlighted in his review article [108].
Furthermore, recent advances in cell-based research in addition to
approaches used to enhance bone tissue engineering are reviewed.
In particular, the use of adipose-derived stem cells (ASCs) for
periodontal tissue regeneration, bone tissue engineering, and the
engineering of complex tissues is discussed. Multiple studies
demonstrated that ASCs have potential uses in bone regeneration,
periodontal tissue regeneration, and further complex therapeutics
involving angiogenesis [109,110]. Furthermore, ASCs secrete sev-
eral soluble factors that have effects on different cell populations.
Because dental treatment is not critical, the successful incorpora-
tion of stem cell-based techniques in dental regenerative medicine
in the future will depend upon key factors, such as low morbidity,
high repeatability, and a high level of safety associated with the
harvesting and implantation of cells. In light of this, regenerative
techniques using ASCs might be among the treatment options
available for various applications in dentistry in the future [108].
Adipose tissue is a mesoderm-derived organ that contains a
stromal population consisting of microvascular endothelial cells,
smooth muscle cells, and stem cells [106]. These cells can be
enzymatically digested out of adipose tissue (commonly from
lipoaspirates) and separated from buoyant adipocytes by centrifu-
gation. A more homogeneous population emerges in culture under
conditions supportive of MSC growth. This population (termed
adipose tissue-derived regenerative cells, ADRCs) shares many of
the characteristics of its counterparts in marrow, including exten-
sive proliferative potential and the ability to undergo multilineage
differentiation [111,112]. Iwaguro and colleagues introduced some
potential clinical applications of adipose-derived regenerative cells
(ADRCs) and ADRC isolation technology in their review article
[113]. Adipose tissue is an abundant source of stem cells and can
be easily harvested and expanded in vitro. Similar to BM-MSCs,
ADRCs can differentiate into multiple mature phenotypes with
potential regenerative applications. Tissue engineering approaches
were used in conjunction with ADRCs for regenerative therapy in
preclinical and clinical settings. In addition, ADRCs appear to be
immunoprivileged, making them ideal candidates for allogeneic
transplantation, potentially enabling “off-the-shelf” therapies.
Adipose tissue is present in abundance in many stores through-
out the body, where it plays a major role in energy balance and
displays strong endocrine functions. ASCs [106] are regarded as
one of the most promising sources for future cell-based therapies
and regenerative medicine. In his review article, Mizuno summar-
ized the underlying biology of ASCs and their proliferation and
differentiation capacities, together with current preclinical and
clinical data, particularly in the ﬁeld of plastic and reconstructive
surgery, in the context of ASC use in regenerative medicine [114].
During the past decade, preclinical studies and clinical trials using
ASCs have been conducted in various medical ﬁelds, from cardi-
ovascular research to applications for corneal diseases. ASCs are
classiﬁed as adult multipotent stem cells, and as such, their
multipotency is limited compared with embryonic stem cells
(ESCs) and induced pluripotent stem (iPS) cells [115]. In addition,
relatively few trials in a limited number of research areas have
been conducted to assess the therapeutic potential of ASCs
compared with the large number of published preclinical studies.
However, ASCs have practical advantages in clinical medicine
because adipose tissue, the primary source of ASCs, is abundant
and easy to obtain, with few donor-site morbidities. Further
preclinical and clinical studies are needed to determine whether
ASC-based therapies can fulﬁll expectations and be used success-
fully to treat disorders for which current medical and surgical
therapies are either ineffective or impractical [116,117].
Periodontitis is a chronic inﬂammatory disease caused by
bacterial bioﬁlms that form on the root surface and is the most
common cause of tooth loss. Therefore, great efforts have been
made to develop therapies to counteract the progression of this
disease. The topical application of recombinant cytokines, such as
platelet-derived growth factor and ﬁbroblast growth factor 2, can
activate endogenous stem cells existing within the periodontal
ligament, resulting in enhancement of periodontal regeneration
[118–120]. These cytokine therapies have been studied in both
preclinical and clinical studies, and concentrated efforts are now
being made to translate these techniques to cell-based therapies
for enhancing periodontal regeneration. In their review article,
Murakami and colleagues focused on ASCs because adipose tissue
is abundant and is easily and safely accessible [121]. Recently, they
demonstrated that transplantation of ASCs enhances periodontal
tissue regeneration in beagle dogs. Additionally, they have already
completed preparations to begin clinical studies to evaluate the
safety and efﬁcacy of ASCs in periodontal tissue regeneration.
In their review, they summarized their knowledge of adipose stem
cell therapies and explored the potential use of such therapy in
periodontal treatment. The topical transplantation of ASCs into
periodontal defects has positive effects on periodontal
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regeneration. Thus, ASCs are a potentially useful cell-based ther-
apy for periodontal regeneration and may be used alongside
existing cytokine-based therapies. Further investigations will gen-
erate detailed information on the true potential of this procedure,
including the extent of periodontal destruction that can be
reversed. In any case, Murakami and colleagues are conﬁdent that
the optimal combination of signaling molecules, scaffold materials,
and stem cells necessary to achieve complete regeneration of the
periodontal tissue destroyed by the progression of periodontal
disease will soon be identiﬁed.
9. “Oral microbiome and bioﬁlm research: new concepts and
new approaches”
All human body sites are colonized by a characteristic microbiota,
the human microbiome, which typically coexists in harmony with
the host. In general, the oral microbiota is responsible for diseases
such as dental caries [122], endodontic infections [123], gingivitis,
and periodontitis [124] in most individuals. Because of the impor-
tance of oral bacteria in these common diseases, the composition
and function of oral bacterial communities in health and disease
have been extensively studied. Such studies have been hampered,
however, by the slow growth, even unculturability, of many oral
bacteria and the recognition that they are present as multispecies
bioﬁlms. Additionally, individual species are not solely responsible
for particular diseases. In his review article, Wade summarized
what is currently known regarding the composition of the oral
microbiome, discussed the development of culture-independent
methods of characterizing oral bacterial communities, with special
reference to next generation sequencing techniques, and discussed
how previously uncultivated bacterial species can be grown such
that their functional potential can be assessed [125]. The introduc-
tion of new, high-throughput molecular characterization methods is
yielding vast quantities of new data concerning the role of oral
bacteria in common dental diseases [126]. Indeed, the difﬁculties
involved in analyzing and interpreting large datasets are currently
the primary bottleneck. They now have a far better understanding of
which bacteria are present in the mouth and which species are
particularly associated with different oral diseases. Furthermore,
disease-associated microbiota are far more complex than previously
thought, and the genetic variation within individual species is also
extremely high. The identiﬁcation of bacteria at the species level
may not be adequate to assess their pathogenicity because indivi-
dual strains within a species can display a wide range of virulence
potential. Thus, it may be better to use modern methods to focus on
the function and pathogenic potential of the whole community,
rather than that of individual species. Metatranscriptomic techni-
ques will be valuable in this context, as they will show which genes
are being transcribed in speciﬁc disease states over time. However,
the precise determination of function requires the study of indivi-
dual live cells and cultures, and it is imperative that efforts to culture
previously uncultivated species are continued and expanded.
Oral diseases are excellent examples of complex diseases, and
the elucidation of their pathogenesis will be valuable for the study
of other, similar human diseases affecting less accessible, body
sites [125].
Hemolysin, which lyses erythrocytes to release hemoglobin, is
an important virulence factor associated with infectious diseases.
Prevotella oris is frequently isolated from oral and systemic
infectious lesions, suggesting that this bacterium is closely related
to purulent inﬂammation [127–131]. In their review article,
Nakazawa and colleagues discussed the puriﬁcation, characteris-
tics, and mechanisms underlying hemolysis-driven cell damage
due to P. oris hemolysin, including hemolysin from other oral
bacteria [132]. P. oris hemolysin was puriﬁed from culture
supernatants by ion-exchange and gel-ﬁltration chromatography
[133]. It was subsequently characterized as a proteinous, thiol-
activated compound with a stronger hemolytic activity toward
human erythrocytes than that toward sheep and rabbit erythro-
cytes. Hemolysin binding experiments showed that P. oris hemo-
lysin binds to erythrocyte membranes in a temperature-
dependent manner before hemolysis. Furthermore, it was sug-
gested that the glycoprotein in erythrocyte membranes is the
potential binding site of P. oris hemolysin. Interestingly, Nakazawa
and colleagues found that glyceraldehyde-3-phosphate dehydro-
genase was released from human erythrocyte membranes when
the cells were lysed by P. oris hemolysin. Additionally, during the
hemolytic process, the release of GAPDH from the cell membrane
to the cytoplasm may be involved in cell damage [134]. However,
the detailed mechanisms underlying the pathogenesis associated
with P. oris hemolysin are still unknown.
The genus Veillonella consists of small, strictly anaerobic, gram-
negative cocci that lack ﬂagella, spores, and a capsule [135]. Oral
Veillonella species have been shown to be associated with many
human oral infectious diseases, especially periodontal diseases
and dental caries. Therefore, understanding the interactions
between Streptococcus and Veillonella in the early stage of oral
bioﬁlm formation may be important to prevent these oral infec-
tious diseases. However, the detailed roles of oral Veillonella
species in bioﬁlm formation have not been fully clariﬁed. Recently,
a novel oral Veillonella species, V. tobetsuensis, was described based
on phylogenetic studies with 16S rDNA, rpoB, and dnaK gene
sequencing [136]. Moreover, V. tobetsuensis has been isolated
frequently from the tongue bioﬁlm of health young adults [137],
and a recent study demonstrated that V. tobetsuensis stimulates
the formation of oral bioﬁlm by Streptococcus gordonii [138]. In
their review article, Mishima and Nakazawa summarized the
phenotypic and phylogenetic characteristics of V. tobetsuensis
and its distribution and frequency in human tongue bioﬁlm
[139]. Furthermore, the effects of V. tobetsuensis on the formation
of bioﬁlm by S. gordonii were also summarized. Using the wire
method, all six oral Veillonella species stimulated the formation of
bioﬁlm by S. gordonii. The greatest amount of bioﬁlm was formed
by S. gordonii in the presence of V. tobetsuensis. These results
suggest that among the oral Veillonella species, V. tobetsuensis
plays an important role in bioﬁlm formation by S. gordonii.
10. “A new concept of bioﬁlm-mediated
oral diseases—symbiosis and dysbiosis—”
Saliva is ubiquitous in the oral cavity and serves a vital role in
the innate immune defense system [140,141]. In order to maintain
the equilibrium within the oral microbial complexes in the mouth,
saliva plays a key role as a defender against invading pathogens
[142–144]. Various antimicrobial peptides in saliva can inhibit
bacterial growth or directly kill microorganisms [145–148]. In their
review article, Scannapieco and colleagues provided a brief update
regarding the potential role of salivary components in bacterial
colonization of the oral cavity [149]. For illustrative purposes,
interactions of salivary components with two species were
described: Streptococcus gordonii, an example of a common oral
commensal species, and S. aureus, a pathogenic species that can
colonize the mouth, especially in individuals at high risk for lung
infections. A number of salivary components have been shown to
interact with both commensal oral bacteria and pathogenic
bacteria that can inﬂuence their colonization of the oral cavity
[150–152]. In fact, hundreds of bacteria that colonize the mouth
can interact with hundreds of salivary components, resulting in an
astronomical number of potential interactions. This underscores
the notion that the mechanisms responsible for bacterial
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colonization of the mouth are extremely complex and difﬁcult to
ascertain. Additional research is necessary to dissect these inter-
actions and ultimately to determine the interactions that are
essential for oral colonization of both commensal and pathogenic
species. Such knowledge may lead to the development of speciﬁc
interventions to control infectious diseases that use the human
mouth as their portal [149].
11. “Mouse genetics approaches decipher molecular
mechanisms of craniofacial development”
Understanding skeletal development is a relevant subject in the
context of medicinal ﬁelds such as orthopedic surgery and dentistry,
because an in-depth understanding of developmental biology will
potentially provide more efﬁcient biological therapeutic strategies that
promote the regeneration and repair of affected skeletal tissue.
Phylogenetic studies of the axial development of higher vertebrates,
such as humans, and other experimental model species, such as mice,
chickens, and zebraﬁsh describe the fundamental developmental
mechanisms of skeletal development that must have evolved from
the body plans of chordate and vertebrate ancestors [153]. Segmenta-
tion of the embryonic body and regionalization of segmented struc-
tures along the body axis are highly conserved processes in both
vertebrates and nonvertebrates [154,155]. The genetic programs of the
segmentation clock and Hox genes provide tight control of the
embryonic body plan and are involved in the formation of the
metamerism of the embryonic body and the morphological informa-
tion of each metameric structure, respectively. Therefore, studies of
skeletal development in vertebrates stimulate the curiosity of both
basic biologists and clinicians. In their review article, Iimura and
colleagues introduced their current understanding of abnormal ver-
tebral segmentation caused by genetic disorders of the components of
a molecular oscillator, the segmentation clock, which is at work in the
embryonic body plan [156]. Their current work using mouse models
has provided an etiological link between the genotypes and pheno-
types of abnormal vertebral disorders and has supported a hypothesis
that is contradictory to the conventional understanding of axial
skeleton patterning, such as the size, shape, and spatial organization
of the skeletal tissue [157]. They also discussed how an integrative
understanding of development biology and clinical research might
provide clues for biological therapeutic strategies that promote the
regeneration and repair of the degenerated spine, whichmostly affects
the elderly. The development of improved therapeutic methods for
degenerated intervertebral discs is highly important and desired in a
society comprising an aging population, as degeneration of interver-
tebral discs is a cause of low back pain, which affects almost 85% of the
population [158]. Current strategies for disc regeneration typically
address the symptoms of low back pain; however, treatments target-
ing the underlying cause of disc degeneration or restoring the
physiological functions of discs remain to be discovered. Therefore,
an improved understanding of the molecular developmental biology
of axial skeleton formation and homeostasis is expected to lay the
foundation for the emergence of new biological treatments to promote
regeneration and repair of the degenerated intervertebral discs.
Interdisciplinary communication and research between basic biologi-
cal researchers and clinical researchers will lead developmental
biology toward translational research [156].
Supernumerary teeth occur in both secondary and deciduous
dentition, although the condition is ﬁve times less frequent in the
latter. The most common case is the presence of a single super-
numerary tooth. Supernumerary teeth are classiﬁed into several
groups based on morphological features and location. Four different
morphological types of supernumerary teeth have been reported:
conical, tuberculate, supplemental, and odontoma. In terms of
location, supernumerary teeth can be divided between two classes:
those found among incisor teeth (also known as mesiodens) and
those found behind premolars. Mesiodens are the most common
type of supernumerary teeth, occurring in 0.15–1.9% of the general
population [159]. They can occur individually or in multiples, may
appear unilaterally or bilaterally, and often do not erupt. Mesiodens
are also frequently associated with various craniofacial anomalies,
such as cleft lip and palate, as well as cleidocranial dysplasia or
Gardner syndrome. Various molecules contribute to the formation
of the functional shape and size of these teeth and participate in the
regulation of the proper number of teeth. In their review article,
Nakamura and Fukumoto discussed the molecular basis for the
regulation of tooth number and supernumerary tooth formation
[160]. Most patients with congenital supernumerary tooth forma-
tion have a heterozygous mutation in the responsible gene. How-
ever, heterozygous deletion of a single gene shows no signiﬁcant
phenotype in mouse models [161–175]. Furthermore, the hetero-
zygous mutation of the interleukin 11 (IL11) gene in humans causes
supernumerary teeth, while IL11-null mice exhibit normal tooth
numbers. Thus, there are some discrepancies in genetic regulation
between humans and mice. Undoubtedly, a sophisticated regulatory
system exists for gene transcription, and elucidation of the mechan-
ism underlying the regulation of tooth number will contribute to
our understanding of the pathogenesis of syndromes involving
abnormal teeth and of odontogenic tumor formation and help with
developing therapeutic strategies to treat these diseases [160].
12. “Cutting edge and perspective of iPS cells research in
dental medicine”
Various tissue engineering technologies have been developed
in recent years using stem cells as a source for missing tissues. iPS
cells, which have similar potential to ES cells, can be generated
through the reprogramming of somatic cells from different tissues
by the forced expression of deﬁned exogenous factors. These iPS
cells can be efﬁciently generated from accessible tissues and have
the potential for use in various clinical applications [176]. Accord-
ingly, these cells have a high degree of availability for regenerative
medicine in dentistry. In the ﬁeld of iPS cell research, researchers
are carrying out various studies in search for an effective technique
for the generation of iPS cells, methods for the safe culture and
transplantation of iPS cells, protocols for the induction of iPS
cells to tissue-speciﬁc cells, and utilization as models of genetic
diseases. In dental research, iPS cells may be applied for the
regeneration of oral tissues and the development of clinical
treatments for congenital diseases. In their review article, Arakaki
et al. mentioned that dental tissue has higher availability for the
production of iPS cells than other tissue types, and iPS cells have
the capacity to differentiate into oral tissue cells, including dental
epithelial and mesenchymal cells [177]. iPS cells can be easily
generated from adult mouse or human gingival ﬁbroblasts
[178,179] and human deciduous tooth dental pulp cells [180] with
minimal discomfort. Elucidation of the mechanisms of cell fate
determination and regeneration of dental epithelial and mesench-
ymal cells from iPS cells by dental epithelial cells may help
develop novel therapeutic approaches in regenerative dentistry
[181,182]. Therefore, iPS cell technology is expected to open new
doors, especially for dental regenerative sciences, although many
hurdles must still be overcome before iPS cells can fulﬁll their
clinical promise.
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